Press Releases Archive

Innovative Fragment Library Concept Allows Identification of New Lead Compounds for Immediate Pre-Clinical Use; Bicoll and Crelux to Market Co-Developed New Fragment Service Platform

Munich (Germany) – December 7, 2011 – BICOLL announced today that it has entered into a sales agreement with CRELUX, a high quality protein and crystallography service provider. The two companies will jointly market their new platform technology to identify a broad range of small active bio-molecules for further (pre-)clinical development. CRELUX will base the …

Bicoll and Naturalpha announce Nutraceutical Research Alliance; European-Funded Research Cooperation Olnorme II Extended

Munich, Germany – July 20, 2011 – Bicoll GmbH, a biopharmaceutical drug discovery company specializing in high-tech natural product chemistry and medicinal chemistry to identify novel small molecules for drug discovery and related innovative fields, and Naturalpha, international consulting, scientific and clinical research company in nutrition and health, partner of food and pharmaceutical industries announced …

Bicoll as Partner of a € 2.7 M European-Funded Euro TransBio Program; Olnorme II Program Focuses on the Development of a New Class of Drug Candidates for the Prevention and Treatment of Cardio Metabolic Diseases with an Inflammatory Component

Munich, Germany – May 11, 2011 – BICOLL GmbH, a biopharmaceutical drug discovery company specializing in high-tech natural product chemistry and medicinal chemistry to identify novel small molecules for drug discovery and related innovative fields, will be responsible for roughly 1 Million Euro of the project volume. As part of the EuroTransBio initiative, the German …

Bicoll and the European Molecular Biology Laboratory (EMBL) announce results of their joint research project on the identification of aurora kinase inhibitors

Munich (Germany), Heidelberg (Germany) – June 22, 2010 – BICOLL GmbH, a biopharmaceutical drug discovery company specializing in high-tech natural product chemistry to identify novel small molecules for drug discovery and related innovative fields and EMBL, the renowned international and inter-governmental research organisation, focusing on molecular biology and biophysics, today announce the successful completion of …

Bicoll Biotechnology (Shanghai) Co. Ltd. receives grant from Shanghai Science Technology Committee

Shanghai, P.R. China – February 22, 2010 – Bicoll Biotechnology (Shanghai) Co. Ltd., a biopharmaceutical company offering pre-clinical support in the area of Drug Discovery from Natural Products and Medicinal Chemistry, announced today that it has received a grant from Shanghai Science Technology Committee. It encourages further investment in science and technology and supports intensified …

Bicoll Biotechnology (Shanghai) Co. Ltd. completes modernization of its laboratory facilities for medicinal chemistry

Shanghai, P.R. China – October 6, 2009 – Bicoll Biotechnology (Shanghai) Co. Ltd., announced today that it has completed the modernization of its laboratory facilities for medicinal chemistry within Zhangjiang Hi-Tech Park, Shanghai to meet increasing demand for its medicinal chemistry capacities. At its central laboratory facility in Shanghai, Bicoll provides pre-clinical support in the …

Bicoll and Genfit announce the identification of active compounds for inflammatory diseases – First candidates de-orphanize nuclear receptor in their joint project OLNORME

Munich (Germany), Lille (France) – September 1, 2009 – BICOLL GmbH, a biopharmaceutical drug discovery company specializing in high-tech natural product chemistry to identify novel small molecules for drug discovery and related innovative fields and GENFIT SA (Alternext: ALGFT; ISIN: FR0004163111), a biopharmaceutical company at the forefront of drug discovery and development, focusing on the …

Bicoll announces a new Advisory Board member – Dr. Michael Bogenstaetter officially appointed to join Bicoll’s Advisory Board

Munich, Germany – June 3, 2009 – The Bicoll GmbH, a biopharmaceutical company specializing in high-tech natural product chemistry to identify novel small molecules for drug discovery and related innovative fields, today announces the appointment of Dr. Michael Bogenstaetter as new member of the Advisory Board. After a one year period of getting acquainted with …

Bicoll announces the signing of a new partnership with Genfit and the partial financing of a 3.2 million euro joint EuroTrans-Bio project by ERA-Net/ European Commission

Munich, Germany – July 3, 2007 – The Bicoll GmbH, a biopharmaceutical company specializing in high-tech natural product chemistry to identify novel small molecules for drug discovery and related innovative fields, today announces the signing of a collaboration agreement with Genfit SA (ALGFT) (Lille, France), a biopharmaceutical company committed to drug discovery and development in …

Ricerca Biosciences, LLC and The Bicoll Group enter significant collaboration agreement

Concord, OH, USA – Munich, Germany – Shanghai, P.R. China – December 6, 2006 – Ricerca Biosciences, LLC and the Bicoll Group today announced the signing of a collaboration agreement. The agreement builds on a long-term relationship between the two companies. Ricerca and Bicoll will combine their strengths in MedChem Services to offer innovative solutions …